Go Pro

Alphatec (ATEC) Competitors

Alphatec logo
$10.03 -0.30 (-2.90%)
Closing price 04:00 PM Eastern
Extended Trading
$9.94 -0.09 (-0.89%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ATEC vs. MMED, TFX, HAE, LIVN, and ITGR

Should you buy Alphatec stock or one of its competitors? Alphatec's main competitors and comparable companies include MiniMed Group (MMED), Teleflex (TFX), Haemonetics (HAE), LivaNova (LIVN), and Integer (ITGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Alphatec compare to MiniMed Group?

Alphatec (NASDAQ:ATEC) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

MiniMed Group has a net margin of 0.00% compared to Alphatec's net margin of -13.49%. MiniMed Group's return on equity of 0.00% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-13.49% -6,752.24% -13.88%
MiniMed Group N/A N/A N/A

Alphatec presently has a consensus target price of $17.40, indicating a potential upside of 73.48%. MiniMed Group has a consensus target price of $23.77, indicating a potential upside of 15.72%. Given Alphatec's stronger consensus rating and higher probable upside, equities analysts plainly believe Alphatec is more favorable than MiniMed Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
1 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.80
MiniMed Group
1 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.75

66.4% of Alphatec shares are held by institutional investors. 13.5% of Alphatec shares are held by insiders. Comparatively, 0.0% of MiniMed Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Alphatec has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$764.16M2.03-$143.36M-$0.71N/A
MiniMed Group$3.10B1.86-$333M-$0.68N/A

In the previous week, MiniMed Group had 1 more articles in the media than Alphatec. MarketBeat recorded 4 mentions for MiniMed Group and 3 mentions for Alphatec. Alphatec's average media sentiment score of 0.75 beat MiniMed Group's score of 0.35 indicating that Alphatec is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MiniMed Group
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Alphatec beats MiniMed Group on 8 of the 14 factors compared between the two stocks.

How does Alphatec compare to Teleflex?

Alphatec (NASDAQ:ATEC) and Teleflex (NYSE:TFX) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

Alphatec has a net margin of -13.49% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-13.49% -6,752.24% -13.88%
Teleflex -39.67%11.93%5.44%

66.4% of Alphatec shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 13.5% of Alphatec shares are held by insiders. Comparatively, 0.7% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Alphatec has higher earnings, but lower revenue than Teleflex. Alphatec is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$764.16M2.03-$143.36M-$0.71N/A
Teleflex$1.99B2.59-$905.64M-$23.29N/A

Alphatec has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market.

In the previous week, Alphatec and Alphatec both had 3 articles in the media. Teleflex's average media sentiment score of 0.90 beat Alphatec's score of 0.75 indicating that Teleflex is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Teleflex
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alphatec currently has a consensus target price of $17.40, suggesting a potential upside of 73.48%. Teleflex has a consensus target price of $152.90, suggesting a potential upside of 25.46%. Given Alphatec's stronger consensus rating and higher probable upside, research analysts clearly believe Alphatec is more favorable than Teleflex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
1 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.80
Teleflex
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.42

Summary

Alphatec and Teleflex tied by winning 8 of the 16 factors compared between the two stocks.

How does Alphatec compare to Haemonetics?

Alphatec (NASDAQ:ATEC) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

66.4% of Alphatec shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 13.5% of Alphatec shares are held by insiders. Comparatively, 2.1% of Haemonetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Haemonetics had 5 more articles in the media than Alphatec. MarketBeat recorded 8 mentions for Haemonetics and 3 mentions for Alphatec. Alphatec's average media sentiment score of 0.75 beat Haemonetics' score of 0.47 indicating that Alphatec is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Haemonetics
3 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Alphatec currently has a consensus price target of $17.40, suggesting a potential upside of 73.48%. Haemonetics has a consensus price target of $99.78, suggesting a potential downside of 6.76%. Given Alphatec's stronger consensus rating and higher probable upside, equities research analysts plainly believe Alphatec is more favorable than Haemonetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
1 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.80
Haemonetics
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

Haemonetics has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$764.16M2.03-$143.36M-$0.71N/A
Haemonetics$1.33B3.65$97.31M$2.0452.46

Alphatec has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market.

Haemonetics has a net margin of 7.12% compared to Alphatec's net margin of -13.49%. Haemonetics' return on equity of 27.55% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-13.49% -6,752.24% -13.88%
Haemonetics 7.12%27.55%9.65%

Summary

Haemonetics beats Alphatec on 11 of the 17 factors compared between the two stocks.

How does Alphatec compare to LivaNova?

Alphatec (NASDAQ:ATEC) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment and valuation.

Alphatec presently has a consensus target price of $17.40, suggesting a potential upside of 73.48%. LivaNova has a consensus target price of $84.13, suggesting a potential upside of 9.03%. Given Alphatec's stronger consensus rating and higher possible upside, equities research analysts plainly believe Alphatec is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
1 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.80
LivaNova
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55

Alphatec has higher earnings, but lower revenue than LivaNova. Alphatec is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$764.16M2.03-$143.36M-$0.71N/A
LivaNova$1.47B2.89-$242.47M$3.3822.83

In the previous week, Alphatec had 1 more articles in the media than LivaNova. MarketBeat recorded 3 mentions for Alphatec and 2 mentions for LivaNova. Alphatec's average media sentiment score of 0.75 beat LivaNova's score of 0.46 indicating that Alphatec is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Alphatec has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

66.4% of Alphatec shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 13.5% of Alphatec shares are owned by insiders. Comparatively, 0.4% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

LivaNova has a net margin of 12.82% compared to Alphatec's net margin of -13.49%. LivaNova's return on equity of 16.35% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-13.49% -6,752.24% -13.88%
LivaNova 12.82%16.35%7.76%

Summary

LivaNova beats Alphatec on 9 of the 16 factors compared between the two stocks.

How does Alphatec compare to Integer?

Alphatec (NASDAQ:ATEC) and Integer (NYSE:ITGR) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

In the previous week, Alphatec and Alphatec both had 3 articles in the media. Alphatec's average media sentiment score of 0.75 beat Integer's score of 0.37 indicating that Alphatec is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Integer has a net margin of 6.97% compared to Alphatec's net margin of -13.49%. Integer's return on equity of 12.79% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-13.49% -6,752.24% -13.88%
Integer 6.97%12.79%6.48%

Integer has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$764.16M2.03-$143.36M-$0.71N/A
Integer$1.85B2.32$102.81M$3.6634.52

66.4% of Alphatec shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 13.5% of Alphatec shares are owned by company insiders. Comparatively, 1.1% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Alphatec presently has a consensus price target of $17.40, suggesting a potential upside of 73.48%. Integer has a consensus price target of $109.86, suggesting a potential downside of 13.04%. Given Alphatec's stronger consensus rating and higher probable upside, equities analysts plainly believe Alphatec is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
1 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.80
Integer
0 Sell rating(s)
13 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.07

Alphatec has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market. Comparatively, Integer has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Summary

Integer beats Alphatec on 9 of the 15 factors compared between the two stocks.

Get Alphatec News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATEC vs. The Competition

MetricAlphatecHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.60B$5.63B$7.32B$13.29B
Dividend YieldN/A1.79%2.52%12.57%
P/E Ratio-14.1325.27274.0125.69
Price / Sales2.0371.49659.4491.39
Price / CashN/A33.0277.8052.76
Price / Book125.385.7810.446.32
Net Income-$143.36M$151.55M$3.49B$359.73M
7 Day Performance-4.48%1.49%0.51%1.35%
1 Month Performance5.80%-3.63%-3.38%-3.68%
1 Year Performance-35.25%6.20%16.04%5.56%

Alphatec Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATEC
Alphatec
4.0291 of 5 stars
$10.03
-2.9%
$17.40
+73.5%
-33.8%$1.60B$764.16MN/A913
MMED
MiniMed Group
1.9115 of 5 stars
$21.97
-2.4%
$23.77
+8.2%
N/A$6.33B$3.22BN/A2,800
TFX
Teleflex
4.7568 of 5 stars
$130.36
-0.5%
$152.90
+17.3%
+1.8%$5.55B$2.25BN/A15,500
HAE
Haemonetics
1.9581 of 5 stars
$106.16
+3.4%
$99.78
-6.0%
+111.9%$4.67B$1.33B52.043,009
LIVN
LivaNova
2.5808 of 5 stars
$80.63
+3.1%
$84.13
+4.3%
+42.4%$4.31B$1.39B23.863,300

Related Companies and Tools


This page (NASDAQ:ATEC) was last updated on 9/23/2026 by MarketBeat.com Staff.
From Our Partners